During the past decade, Innovaderm Research Inc. conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 44 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 30 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Innovaderm Research Inc." #1 sponsor was "Innovaderm Research Inc." with 25 trials, followed by "Pfizer" with 22 trials sponsored, "Boehringer Ingelheim" with 6 trials sponsored, "Dermira, Inc." with 6 trials sponsored and "Eli Lilly and Company" with 6 trials sponsored. Other sponsors include 52 different institutions and companies that sponsored additional 40 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Innovaderm Research Inc." #1 collaborator was "Abbott" with 5 trials as a collaborator, "Amgen" with 4 trials as a collaborator, "Innovaderm Research Inc." with 4 trials as a collaborator, "Montreal Heart Institute" with 3 trials as a collaborator and "Incyte Corporation" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Innovaderm Research Inc." are "Psoriasis" (31 trials), "Atopic Dermatitis" (19 trials), "Dermatitis, Atopic" (13 trials), "Plaque Psoriasis" (11 trials) and "Acne Vulgaris" (8 trials). Many other conditions were trialed in "Innovaderm Research Inc." in a lesser frequency.

Most popular intervention types in "Innovaderm Research Inc." are "Drug" (101 trials), "Other" (21 trials), "Biological" (7 trials), "Device" (6 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (36 trials), "Vehicle" (7 trials), "ASN002" (4 trials), "Adalimumab" (3 trials) and "CP-690,550" (3 trials). Other intervention names were less common.

The vast majority of trials in "Innovaderm Research Inc." are 119 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Innovaderm Research Inc.". undefined are not yet recruiting, 5 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 98 completed trials in Innovaderm Research Inc., undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Innovaderm Research Inc., 15 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 10 trials, and there were also 7 trials that are defined as “Not Applicable".

Innovaderm Research Inc. has several departments that took part in Clinical trials: "International Dermatology Research, Inc." - 3 trials